Co-Authors
This is a "connection" page, showing publications co-authored by DIMA SUKI and AMY B HEIMBERGER.
Connection Strength
0.677
-
A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdaa146.
Score: 0.197
-
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro Oncol. 2006 Jul; 8(3):261-79.
Score: 0.073
-
Innate immune functions of microglia isolated from human glioma patients. J Transl Med. 2006 Mar 30; 4:15.
Score: 0.072
-
The natural history of EGFR and EGFRvIII in glioblastoma patients. J Transl Med. 2005 Oct 19; 3:38.
Score: 0.069
-
Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients. Clin Cancer Res. 2005 Feb 15; 11(4):1462-6.
Score: 0.066
-
Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas. Clin Cancer Res. 2005 Jan 01; 11(1):267-72.
Score: 0.066
-
Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes. Neurosurgery. 2020 01 01; 86(1):112-121.
Score: 0.046
-
A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors. J Neurosurg. 2013 Apr; 118(4):873-883.
Score: 0.029
-
Awake craniotomy for brain tumors near eloquent cortex: correlation of intraoperative cortical mapping with neurological outcomes in 309 consecutive patients. Neurosurgery. 2009 May; 64(5):836-45; discussion 345-6.
Score: 0.022
-
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma. J Clin Oncol. 2007 Jun 01; 25(16):2288-94.
Score: 0.019
-
Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Clin Cancer Res. 2006 Jul 01; 12(13):3935-41.
Score: 0.018